Try our beta test site

FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer (FASTR)

This study has been terminated.
(Higher then expected Gr3 GU/GI toxicity)
Information provided by (Responsible Party):
George Rodrigues, Lawson Health Research Institute Identifier:
First received: September 21, 2011
Last updated: July 22, 2014
Last verified: July 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: No date given
  Estimated Primary Completion Date: December 2021 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):